Chad Robins, Adaptive Biotechnologies CEO (Adaptive via YouTube)
March 10, 2022 10:44 AM EST
People
Diagnostics

An­oth­er biotech is feel­ing the heat as it un­der­goes 're­or­ga­ni­za­tion' with plans to lay off about 100

Max Gelman

Senior Editor

Adap­tive Biotech­nolo­gies is join­ing the horde of biotechs that have been forced to lay off staff in the wake of grow­ing mar­ket chal­lenges.

The Seat­tle …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

ADC biotech Ad­cen­do nabs $135M Se­ries B as it en­ters the clin­ic

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Cas­sa­va shares plunge as con­tro­ver­sial Alzheimer’s drug fails Phase 3 tri­al

Gilead buys ex­per­i­men­tal HIV vac­cines from a small Barcelona biotech

A service from the Financial Times